Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 3
2012 1
2013 1
2018 2
2019 5
2020 10
2021 3
2022 9
2023 6
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for zheng yan lv
Search for Zhengyan Lv instead (2 results)
Noncoding RNAs in gastric cancer: implications for drug resistance.
Wei L, Sun J, Zhang N, Zheng Y, Wang X, Lv L, Liu J, Xu Y, Shen Y, Yang M. Wei L, et al. Among authors: zheng y. Mol Cancer. 2020 Mar 19;19(1):62. doi: 10.1186/s12943-020-01185-7. Mol Cancer. 2020. PMID: 32192494 Free PMC article. Review.
Genetic risk, incident gastric cancer, and healthy lifestyle: a meta-analysis of genome-wide association studies and prospective cohort study.
Jin G, Lv J, Yang M, Wang M, Zhu M, Wang T, Yan C, Yu C, Ding Y, Li G, Ren C, Ni J, Zhang R, Guo Y, Bian Z, Zheng Y, Zhang N, Jiang Y, Chen J, Wang Y, Xu D, Zheng H, Yang L, Chen Y, Walters R, Millwood IY, Dai J, Ma H, Chen K, Chen Z, Hu Z, Wei Q, Shen H, Li L. Jin G, et al. Among authors: zheng y. Lancet Oncol. 2020 Oct;21(10):1378-1386. doi: 10.1016/S1470-2045(20)30460-5. Lancet Oncol. 2020. PMID: 33002439
Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease.
Varcoe RL, DeRubertis BG, Kolluri R, Krishnan P, Metzger DC, Bonaca MP, Shishehbor MH, Holden AH, Bajakian DR, Garcia LA, Kum SWC, Rundback J, Armstrong E, Lee JK, Khatib Y, Weinberg I, Garcia-Garcia HM, Ruster K, Teraphongphom NT, Zheng Y, Wang J, Jones-McMeans JM, Parikh SA; LIFE-BTK Investigators. Varcoe RL, et al. Among authors: zheng y. N Engl J Med. 2024 Jan 4;390(1):9-19. doi: 10.1056/NEJMoa2305637. Epub 2023 Oct 25. N Engl J Med. 2024. PMID: 37888915 Clinical Trial.
Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma.
Tian XP, Zhang YC, Lin NJ, Wang L, Li ZH, Guo HG, Ma SY, An MJ, Yang J, Hong YH, Wang XH, Zhou H, Li YJ, Rao HL, Li M, Hu SX, Lin TY, Li ZM, Huang H, Liang Y, Xia ZJ, Lv Y, Liu YY, Duan ZH, Chen QY, Wang JN, Cai J, Xie Y, Ong CK, Liu F, Liu YY, Yan Z, Huang L, Tao R, Li WY, Huang HQ, Cai QQ. Tian XP, et al. Among authors: yan z. Cell Rep Med. 2023 Feb 21;4(2):100859. doi: 10.1016/j.xcrm.2022.100859. Cell Rep Med. 2023. PMID: 36812892 Free PMC article.
Multi-modal molecular determinants of clinically relevant osteoporosis subtypes.
Yuan C, Yu XT, Wang J, Shu B, Wang XY, Huang C, Lv X, Peng QQ, Qi WH, Zhang J, Zheng Y, Wang SJ, Liang QQ, Shi Q, Li T, Huang H, Mei ZD, Zhang HT, Xu HB, Cui J, Wang H, Zhang H, Shi BH, Sun P, Zhang H, Ma ZL, Feng Y, Chen L, Zeng T, Tang DZ, Wang YJ. Yuan C, et al. Among authors: zheng y. Cell Discov. 2024 Mar 12;10(1):28. doi: 10.1038/s41421-024-00652-5. Cell Discov. 2024. PMID: 38472169 Free PMC article.
Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients.
Zhang F, Zhang R, Zong J, Hou Y, Zhou M, Yan Z, Li T, Gan W, Lv S, Yang L, Zeng Z, Zhao W, Yang M. Zhang F, et al. Among authors: yan z. Front Immunol. 2023 Oct 19;14:1279789. doi: 10.3389/fimmu.2023.1279789. eCollection 2023. Front Immunol. 2023. PMID: 37928532 Free PMC article.
42 results